stockportfolio.pro
Stocks / GEHC vs RVMD
GEHC vs RVMD
GE HealthCare Technologies Inc. and Revolution Medicines, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| GE HealthCare Technologies Inc. (GEHC) | Revolution Medicines, Inc. (RVMD) | |
|---|---|---|
| Market cap | $29.5B | $31.3B |
| Revenue (latest FY) | $20.63B | $0 |
| Net income (latest FY) | $2.08B | $-1.13B |
| Revenue growth (5y CAGR) | 4.1% | — |
| Net margin | 10.1% | — |
| Return on equity | 20.1% | -69.3% |
| P/E ratio | 15.5 | — |
| Dividend yield | 0.2% | — |
| Profitable years (of last 10) | 5 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open GEHC — free Open RVMD — freeFrequently asked questions
Which is bigger, GEHC or RVMD?
Revolution Medicines, Inc. is larger by market capitalization — $31.3B versus $29.5B.
Which grows faster, GEHC or RVMD?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.